DRUGS MADE IN AMERICA ACQUISITION CORP.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $1.7M | $2.0M | $213.0K | $2.2M | $2.3M | $1.3M |
| Depreciation & Amortization | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-244.6K | $-91.3K | $-125.2K | $-56.1K | $-106.7K | $-251.2K |
| Investing Activities | ||||||
| Capital Expenditures | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $0 | $0 | $0 | $-231.2M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-98.5M | $100.0K | $130.6K | $56.0K | $106.6K | $231.4M |
| Net Change in Cash | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — |